Schedule 13D ownership disclosure

Spark Therapeutics, Inc.

Security class unavailable · CUSIP: 84652J103

Event date: 2015-10-07

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,589,032
Percent of class
6.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-15-060228
Form type
SC 13D/A
Filer
Sofinnova Venture Partners VIII, L.P.
CIK
CIK 1524064
Filed
Oct 21, 2015
Reporting period
Oct 07, 2015
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub